SCHEMBL10644719

SCHEMBL10644719

O=C(O)CS(=O)(=O)c1ccc2c(-c3ccccc3F)noc2c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.39
▸ GPBAR1 Q8TDU6 2/20 0.37
▸ FFAR1 O14842 2/20 0.36
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CYP2C19 P33261 1/20 0.32
▸ HTR7 P34969 1/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ MMP2 P08253 1/20 0.32
▸ MMP7 P09237 1/20 0.32
▸ MMP14 P50281 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ MAOA P21397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11016219 0.86 GPBAR1 (0.38) PTGS1GPBAR1RAB9AKMT2AHPGD
SCHEMBL10647120 0.81 PTGDR2 (0.36) GPBAR1NPC1RAB9AFFAR4LMNA
SCHEMBL10642629 0.81 GPBAR1 (0.38) PTGS1GPBAR1NPC1RAB9ASMN1; SMN2
SCHEMBL10645064 0.80 GPBAR1 (0.36) PTGS1GPBAR1NPC1RAB9ALMNA
SCHEMBL10737555 0.76 STK17B (0.38) PTGS1GPBAR1NPC1RAB9AMEN1
SCHEMBL4035353 0.76 FFAR4 (0.44) PTGS1GPBAR1FFAR1FFAR4HPGD
SCHEMBL10842370 0.75 FFAR1 (0.46) GPBAR1FFAR1NPC1RAB9AMMP2
SCHEMBL10845047 0.75 FFAR1 (0.37) PTGS1GPBAR1FFAR1NPC1RAB9A
SCHEMBL10642927 0.75 GPBAR1 (0.36) PTGS1GPBAR1NPC1RAB9AFFAR4
SCHEMBL10658344 0.74 PTGS1 (0.42) PTGS1GPBAR1NPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0147691-B1 ANTIHYPERTENSIVE 3-ARYL-1,2-BENZISOXAZOLSULFONYL AND-SULFINYL-ALKANOIC ACIDS, A PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-01-20 — — EP claimed
US-4602028-A Antihypertensive 3-aryl-1,2-benzisoxazol-sulfonyl and sulfinylalkanoic acids HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1986-07-22 — — US claimed
EP-0147691-A1 Antihypertensive 3-aryl-1,2-benzisoxazolsulfonyl and-sulfinyl-alkanoic acids, a process for their preparation and their use for the preparation of medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-07-10 — — EP claimed
EP-0147691-B1 ANTIHYPERTENSIVE 3-ARYL-1,2-BENZISOXAZOLSULFONYL AND-SULFINYL-ALKANOIC ACIDS, A PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-01-20 — — EP disclosed
US-4602028-A Antihypertensive 3-aryl-1,2-benzisoxazol-sulfonyl and sulfinylalkanoic acids HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1986-07-22 — — US disclosed
EP-0147691-A1 Antihypertensive 3-aryl-1,2-benzisoxazolsulfonyl and-sulfinyl-alkanoic acids, a process for their preparation and their use for the preparation of medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-07-10 — — EP disclosed
Send feedback